| Application no. and date | 15757389.0 (espacenet) (Federated) (European Patent Register), 20150820 | | Patent/reg. no. and date | DK/EP 3182996, 20221228 | | Publication date | 20170628 | | Priority no. and date | US 201462040918 P, 20140822 | | EP pub. no. and date |
EP 3182996 20170628 | | Effective date | | | Applicant/owner | Celgene Corporation, 86 Morris Avenue
Summit, NJ 07901, US | | Applicant ref. no. | P81615DK01 | | Inventor | THAKURTA, Anjan, 30 Benedict Cres.
Basking Ridge, NJ 07920, US,
HUSSEIN, Mohamed, 16107 Copeland Farms Rd.
Odessa, FL 33556, US,
JACQUES, Christian, 4499 Rudetown Rd.
Hamburg, NJ 07419, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/454 (2006.01) , A61K 31/5377 (2006.01) , A61K 31/573 (2006.01) , A61K 31/69 (2006.01) , A61K 35/28 (2015.01) , A61K 39/00 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | FREMGANGSMÅDER TIL BEHANDLING AF MYELOMATOSE MED IMMUNMODULATORISKE FORBINDELSER I KOMBINATION MED ANTISTOFFER | | Int. application no. | US2015046091 | | Int. publication no. | WO2016029004 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
